We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCI icon
376
Service Corp International
SCI
$11.5B
$7.92M 0.03%
179,118
+56,308
+46% +$2.27M
EGBN icon
377
Eagle Bancorp
EGBN
$879M
$7.89M 0.03%
155,918
-258,238
-62% -$14.3M
EMN icon
378
Eastman Chemical
EMN
$7.8B
$7.82M 0.03%
81,725
-8,994
-10% -$892K
IJH icon
379
iShares Core S&P Mid-Cap ETF
IJH
$124B
$7.82M 0.03%
+194,235
New +$7.81M
MMP
380
DELISTED
Magellan Midstream Partners, L.P.
MMP
$7.75M 0.03%
114,491
-3,290
-3% -$228K
CAH icon
381
Cardinal Health
CAH
$53.5B
$7.73M 0.03%
143,158
-76,233
-35% -$3.9M
KNBWY
382
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
$7.58M 0.03%
295,714
+17,503
+6% +$449K
XLE icon
383
State Street Energy Select Sector SPDR ETF
XLE
$39.2B
$7.57M 0.03%
199,966
-4,162
-2% -$156K
VUG icon
384
Vanguard Growth ETF
VUG
$219B
$7.55M 0.03%
+281,490
New +$7.36M
VTV icon
385
Vanguard Value ETF
VTV
$190B
$7.49M 0.03%
+67,703
New +$7.39M
RNR icon
386
RenaissanceRe
RNR
$13.7B
$7.42M 0.03%
55,584
-929
-2% -$120K
MOH icon
387
Molina Healthcare
MOH
$10.3B
$7.42M 0.03%
49,900
PEG icon
388
Public Service Enterprise Group
PEG
$39.7B
$7.33M 0.03%
138,807
-9,141
-6% -$477K
IWB icon
389
iShares Russell 1000 ETF
IWB
$48.2B
$7.13M 0.03%
+44,075
New +$7M
AZO icon
390
AutoZone
AZO
$49.3B
$6.91M 0.03%
8,910
+4,924
+124% +$3.62M
MAGN
391
Magnera Corp
MAGN
$498M
$6.88M 0.03%
27,685
SBUX icon
392
Starbucks
SBUX
$119B
$6.82M 0.03%
119,960
+28,845
+32% +$1.53M
AV
393
DELISTED
Aviva Plc
AV
$6.73M 0.03%
526,853
-3,384
-0.6% -$43.2K
PRU icon
394
Prudential Financial
PRU
$42B
$6.58M 0.03%
64,941
-457
-0.7% -$45K
KR icon
395
Kroger
KR
$35B
$6.56M 0.03%
225,420
+7,066
+3% +$210K
CNDT icon
396
Conduent
CNDT
$234M
$6.55M 0.03%
290,963
+77,240
+36% +$1.59M
VEEV icon
397
Veeva Systems
VEEV
$31B
$6.54M 0.03%
60,064
+59,414
+9,141% +$5.39M
RDS.B
398
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$6.54M 0.03%
92,196
+450
+0.5% +$31.2K
WBK
399
DELISTED
Westpac Banking Corporation
WBK
$6.54M 0.03%
326,769
+5,882
+2% +$124K
NVS icon
400
Novartis
NVS
$297B
$6.5M 0.03%
84,212
-11,375
-12% -$841K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.